Study finds one shot of HPV vaccine just as effective as two; cervical cancer screening guidelines updated
A study published Dec. 3 by the New England Journal of Medicine found that one dose of the HPV vaccine could be as effective as two in preventing cervical cancer. The study, led by the National Cancer Institute, consisted of a randomized trial of 20,320 girls ages 12-16. In addition, the American Cancer Society Dec. 4 announced updated guidelines for cervical cancer screening, saying that self-collection of vaginal samples for HPV testing is now optional, although clinician-collected samples are preferred.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services April 13 announced that more than 150 organizations have been accepted to participate in the launch of its…
Headline
The AHA and dozens of other organizations April 14 sent a letter of support to Reps. Suzan DelBene, D-Wash., and Mike Kelly, R-Pa., for their introduction…
Headline
The Department of Health and Human Services and Centers for Medicare & Medicaid Services announced members of the Healthcare Advisory Committee March 26.…
Headline
An American Heart Association study published March 25 found that children born to mothers with premature placental separation could be at higher risk of heart…
Headline
A JAMA study published March 18 found that women who experience premature menopause have a 40% higher lifetime risk of coronary heart disease. Approximately 15…
Headline
The American College of Cardiology, American Heart Association and nine other medical associations March 13 released updated guidelines on managing cholesterol…